Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: FDA Medical Device Regulations Experts: Legal, Economic, and Regulatory Affairs

Council Members in this Study Group: 52

This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Richard Tarplin

Principal
Tarplin Strategies, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives...

Stephen Bent, Partner, FOLEY & LARDNER LLPStephen Bent

Partner
FOLEY & LARDNER LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr....

Thomas Saunders, Of Counsel, RISSMAN HENDRICKS & OLIVERIO, LLPThomas Saunders

Of Counsel
RISSMAN HENDRICKS & OLIVERIO, LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Thomas Saunders is an Of Counsel at Rissman Hendricks & Oliverio. He specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy, IP licensing...

2 news post(s)
Marc Scheineson, Partner & Chair, Food and Drug Practice, ALSTON & BIRD LLPMarc Scheineson

Partner & Chair, Food and Drug Practice
ALSTON & BIRD LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Marc Scheineson is a Partner with Alston & Bird where he heads the firm's Food and Drug Law Practice. He has practiced food and drug law, health care law and administrative law for over 20 years in national law firms and at the FDA. His practice focuses...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

RIPENING INHIBITORS: ROSY FUTURE OR BRUISED FRUIT?

December 21, 2007

Analysis by:Thomas Saunders, Of Counsel,

Current and Potential Commercial Applicationsof the Suppression of Ethylene Action by 1-MCP in Plants | www.rohmhaas.com

    Product shelf-life is a major economic concern for the agricultural industry.   The biological mechanism for regulating the ripening of fruits is mediated by ethylene.     Ethylene  management is addressed in three ways: 1) Ethylene absorption 2) Inhibition of ethylene biosynthesis and 3) Prevention of ethylene receptor signaling.     In the ripening control patent landscape novel cyclopropene compounds function as ethylene receptor blockers.  Of the 60 U.S. patents that have issued, approximately 15 are related to cyclopropenes, while the remaining 45 are more or less evenly distributed between about 20 different ethylene management technologies. AgroFresh Inc., a Rohm and Haas subsidiary, has staked out a significant position in ethylene receptor blocking technology by claiming a wide range of cyclopropene derivatives

Defending Knock-Offs: Head-to-head With Brand Names in Trademark, Copyright, and Internet Marketing

March 1, 2007

Analysis by:Thomas Saunders, Of Counsel,

Defending Knock-Offs: Head-to-head With Brand Names in Trademark, Copyright, and Internet Marketing | www.iptoday.com

-Name Brands vs, Knock-Offs: Strategies and Counter-Strategies

-Vulnerabilities of Name Brand Copyrights

-Why the internet Knock-Off market will always exist

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Law Firm (general practice/large)
  • Law Firm (Boutique / Specialized)
  • Consultancy, Healthcare-Focused
  • Lobbying Firm
  • Academic Medical Center/Hospital or Clinic
  • Advocacy Group or Issue Focused

Members in this Study Group often have these job titles:

  • Partner
  • Principal
  • Director
  • Vice President

Related Study Groups

Study Group Name No. Members
FDA Medical Device Experts: Lawyers 29
FDA Regulation Experts: Legal, Economic, and Regulatory Affairs (Washington DC) 47
Pharmaceutical Regulation and FDA Experts: Lawyers 48
FDA Regulation Experts: Lawyers (Washington, DC) 32
CMS Medical Device Experts: Legal, Economic, and Regulatory Affairs 31
Medical Device Experts 317
CMS Pharmaceutical and Biotechnology Reimbursement Experts: Legal, Economic, and Regulatory Affairs 55
Council Members in the U.S. who are Familiar with Regulations Pertaining to Andrx Corporation's Form 483 18